Cocrystal Pharma 8-K: Security Holder Vote Matters
Ticker: COCP · Form: 8-K · Filed: Jul 1, 2025 · CIK: 1412486
| Field | Detail |
|---|---|
| Company | Cocrystal Pharma, INC. (COCP) |
| Form Type | 8-K |
| Filed Date | Jul 1, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
TL;DR
Cocrystal Pharma shareholders voted on key company matters on June 25, 2025.
AI Summary
Cocrystal Pharma, Inc. filed an 8-K on June 25, 2025, reporting on matters submitted to a vote of its security holders. The filing details the company's corporate actions and governance, as required by the SEC for significant events.
Why It Matters
This filing indicates that important decisions requiring shareholder approval were made, which could impact the company's strategic direction and future operations.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of matters voted on by security holders and does not contain new financial or operational risks.
Key Players & Entities
- Cocrystal Pharma, Inc. (company) — Registrant
- June 25, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-38418 (company_id) — Commission File Number
- 35-2528215 (ein) — IRS Employer Identification No.
- 19805 N. Creek Parkway Bothell, WA 98011 (address) — Principal executive offices
- (786) 459-1831 (phone_number) — Registrant's telephone number
FAQ
What specific matters were submitted to a vote of Cocrystal Pharma, Inc.'s security holders on June 25, 2025?
The filing states that matters were submitted to a vote of security holders, but the specific details of these matters are not provided in the excerpt.
What is the exact date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is June 25, 2025.
In which U.S. state is Cocrystal Pharma, Inc. incorporated?
Cocrystal Pharma, Inc. is incorporated in Delaware.
What is the Commission File Number for Cocrystal Pharma, Inc.?
The Commission File Number for Cocrystal Pharma, Inc. is 001-38418.
What is the principal executive office address for Cocrystal Pharma, Inc.?
The principal executive office address is 19805 N. Creek Parkway, Bothell, WA 98011.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 1, 2025 regarding Cocrystal Pharma, Inc. (COCP).